Skip to content
MMR Sign In Subscribe
Supplier News — Camber Pharmaceuticals

Camber adds Magnesium Sulfate Injection to portfolio

Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency.

,   and  CDR
1 min read

PISCATAWAY, NJ – Camber, a leader in generic drug approvals and launches, is proud to add Magnesium Sulfate Injection, USP [mag-NEE-see-um-SUL-fate] to its growing portfolio.

Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.

Magnesium Sulfate Injection, USP is available in:

Strength

Size

1g / 2mL (500mg per mL) *

25 x 2 mL Single-Dose Vials

5g / 10mL (500mg per mL)

25 x 10 mL Single-Dose Vials

10g / 20mL (500mg per mL)

25 x 20 mL Single-Dose Vials

25g / 50mL (500mg per mL) *

25 x 50 mL Single-Dose Vials

*Camber Pharmaceuticals has 180-day exclusivity on 1g / 2mL (500mg per mL) and 25g / 50mL (500mg per mL).

 To learn more about this product, visit: www.camberpharma.com/magnesium-sulfate

Related

Latest